Obtenez une réponse de cet employeur
Votre CV et votre lettre de motivation, adaptés exactement à ce que l’employeur recherche.
Cell Signaling and Apoptosis Group (CSA) at the Universitat de Lleida- IRBLleida (Spain) is seeking a highly motivated prospective PhD candidate with a background in biomedical sciences, biotechnology, biochemistry or related disciplines.
The selected candidate will receive support to apply for national and local predoctoral contracts (FPU, FI-Joan Oró, UdL-Banco Santander) and will investigate cardiac fibrosis using cellular and animal models within the CardioAdapt project.
Organisation / Company Universitat de Lleida Department Basic Medical Sciences Laboratory Cell Signaling and Apoptosis Group Is the Hosting related to staff position within a Research Infrastructure? No
Cell signaling and Apoptosis Group (CSA) at the Universitat de Lleida- IRBLleida (Spain) is seeking a highly motivated prospective PhD candidate with a background in biomedical sciences, biotechnology, biochemistry or related disciplines.
The selected candidate will receive support to apply for national and local predoctoral contracts (FPU, FI-Joan Oró, UdL-Banco Santander).
We are particularly interested in candidates who wish to investigate cardiac fibrosis using cellular and animal models. The successful candidate will contribute to an ongoing, competitively funded research program investigating cardiac fibroblast adaptation to stresses that originate fibrosis and heart disfunction.
The PhD will be embedded within the research project CardioAdapt: “Integrative discovery of adaptive fibroblast signaling underlying resilience in cardiac fibrosis and heart failure” funded by the Spanish Ministry of Science and Innovation (MICIU). The project investigates the response of cardiac fibroblasts to heart failure and metabolic stress conditions that lead to cardiac fibrosis. The project focuses on cell signaling pathways, mitochondrial stress and metabolic alterations, integrating cellular, animal, and human data with a strong emphasis on sex as a biological variable. The key pathways include DEPTOR–mTOR signaling and the mitochondrial nucleases ENDOG and EXOG.
Candidates must hold a Bachelor’s and a Master’s degree (or be enrolled in a Master’s programme to be completed before the start date) in Biomedical Sciences, Biotechnology, Biology or related fields, eligible for admission at the PhD program in Health of Universitat de Lleida.
A minimum average academic grade of 6.5/10 (Spanish scale) in the Bachelor’s degree is required. Candidates with foreign degrees must provide the official grade equivalence to the Spanish scale (Declaración de equivalencia de nota media, Minsterio de Ciencia, Innovación y Universidades)